Ligand-targeted theranostic nanomedicines against cancer
Journal Article
·
· Journal of Controlled Release
Not Available
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1236080
- Journal Information:
- Journal of Controlled Release, Journal Name: Journal of Controlled Release Journal Issue: C Vol. 240; ISSN 0168-3659
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- Netherlands
- Language:
- English
Similar Records
Mathematical modeling in cancer nanomedicine: a review
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer
Gold nanoparticles for cancer theranostics — A brief update
Journal Article
·
2019
· Biomedical Microdevices
·
OSTI ID:1623615
+5 more
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer
Journal Article
·
2023
· Nuclear Medicine and Biology
·
OSTI ID:1993381
+10 more
Gold nanoparticles for cancer theranostics — A brief update
Journal Article
·
2016
· Journal of Innovative Optical Health Sciences
·
OSTI ID:1437935
+1 more